Lastentautien vastuualue

Julkaisut 2012
Publications 2012

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Aitken EH et al. Antibody to P. falciparum in pregnancy varies with intermittent preventive treatment regime and bed net use.
2 Arvola T et al. Potilastietojärjestelmien turvallisuusriskit hallintaan.
3 Arvonen M et al. Altered expression of intestinal human leucocyte antigen D-related and immune signalling molecules in juvenile idiopathic arthritis.
4 Castellanos-rubio A et al. Angiogenesis-related gene expression analysis in celiac disease.
5 Collin P et al. Transient celiac autoimmunity or just temporary fluctuation.
6 Erkkola M et al. Risk of asthma and allergic outcomes in the offspring in relation to maternal food consumption during pregnancy: a Finnish birth cohort study.
7 Eskola V, Korppi M. Bronkioliitti.
8 Firtser S et al. Relation of total and free testosterone and sex hormone-binding globulin with cardiovascular risk factors in men aged 24-45 years. The Cardiovascular Risk in Young Finns Study.
9 Giaquinto C et al. Report of the second European expert meeting on rotavirus vaccination.
10 Giersiepen K et al. Accuracy of diagnostic antibody tests for coeliac disease in children: summary of an evidence report.
11 Gribouval O et al. Spectrum of mutations in the renin-angiotensin system genes in autosomal recessive renal tubular dysgenesis.
12 Grzeskowiak L et al. Distinct gut microbiota in southeastern African and northern European infants.
13 Grönholm J. Evolutionary conserved regulatory mechanism of the JAK/STAT pathway.
14 Grönholm J et al. Not4 enhances JAK/STAT pathway-dependent gene expression in Drosophila and in human cells.
15 Haarala A et al. Relation of high cytomegalovirus antibody titres to blood pressure and brachial artery flow-mediated dilation in young men: the Cardiovascular Risk in Young Finns Study.
16 Hakkarainen E et al. Stimulus evaluation, event preparation, and motor action planning in young patients with mild spastic cerebral palsy: an event-related brain potential study.
17 Hannonen R et al. Academic skills in children with early-onset type 1 diabetes: the effects of diabetes-related risk factors.
18 Hartiala O et al. Adolescence risk factors are predictive of coronary artery calcification at middle age: the cardiovascular risk in young Finns study.
19 Heikinheimo M et al. Tämän päivän tutkimus on huomispäivän hoitoa.
20 Helin A et al. Iron intake, haemoglobin and risk of gestational diabetes: a prospective cohort study.
21 Helminen M et al. A novel mutation W388X underlying properdin deficiency in a Finnish family.
22 Helmiö P et al. First year with WHO Surgical Safety Checklist in 7148 otorhinolaryngological operations: use and user attitudes.
23 Hemming M, Vesikari T. Vaccine-derived human-bovine double reassortant rotavirus in infants with acute gastroenteritis.
24 Hernesniemi JA et al. Genetic profiling using genome-wide significant coronary artery disease risk variants does not improve the prediction of subclinical atherosclerosis: the Cardiovascular Risk in Young Finns Study, the Bogalusa Heart Study and the Health 2000 Survey--...
25 Husby S et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease.
26 Hyödynmaa E et al. Frequency and clinical correlates of radiographic patterns of bronchopulmonary dysplasia in very low birth weight infants by term age.
27 Ilus T et al. Persistent duodenal intraepithelial lymphocytosis despite a long-term strict gluten-free diet in celiac disease.
28 Jauhola O et al. Outcome of Henoch-Schönlein purpura 8 years after treatment with a placebo or prednisone at disease onset.
29 Juhola J et al. Childhood physical, environmental, and genetic predictors of adult hypertension: the cardiovascular risk in young Finns study.
30 Julkunen MK et al. Obstetric parameters and Doppler findings in cerebral circulation as predictors of 1 year neurodevelopmental outcome in asphyxiated infants.
31 Jylhävä J et al. A Genome-Wide Association Study Identifies UGT1A1 as a Regulator of Serum Cell-Free DNA in Young Adults: The Cardiovascular Risk in Young Finns Study.
32 Jääskeläinen P et al. Childhood nutrition in predicting metabolic syndrome in adults: the cardiovascular risk in young Finns study.
33 Kaikkonen R et al., toim. Lasten ja lapsiperheiden terveys- ja hyvinvointierot.
34 Kalavainen M et al. Impact of childhood obesity treatment on body composition and metabolic profile.
35 Karjalainen AK et al. Long-term daily intake estimates of polychlorinated dibenzo-p-dioxins and furans, polychlorinated biphenyls and polybrominated diphenylethers from food in Finnish children: risk assessment implications.
36 Karvonen AM et al. Exposure to microbial agents in house dust and wheezing, atopic dermatitis and atopic sensitization in early childhood: a birth cohort study in rural areas.
37 Kaukinen K et al. Screening programs for coeliac disease. Authors’ response.
38 Kaukinen K, Lähdeaho ML. Challenge of measuring how much gluten is too much.
39 Kestilä P et al. Socioeconomic status, cardiovascular risk factors, and subclinical atherosclerosis in young adults: the cardiovascular risk in Young Finns Study.
40 Kinos S et al. Burden of Illness in Screen-detected Children With Celiac Disease and Their Families.
41 Knip M. Descriptive epidemiology of type 1 diabetes--is it still in.
42 Knip M. The role of hygiene in the development of type 1 diabetes.
43 Knip M, Simell O. Environmental triggers of type 1 diabetes.
44 Koho T et al. Purification of norovirus-like particles (VLPs) by ion exchange chromatography.
45 Koivistoinen T et al. Arterial pulse wave velocity in relation to carotid intima-media thickness, brachial flow-mediated dilation and carotid artery distensibility: the Cardiovascular Risk in Young Finns Study and the Health 2000 Survey.
46 Kolehmainen P et al. Human parechoviruses are frequently detected in stool of healthy Finnish children.
47 Koponen P et al. Association of MBL2 polymorphism with asthma after bronchiolitis in infancy.
48 Koponen P et al. Preschool asthma after bronchiolitis in infancy.
49 Korppi M. Lung function after viral early childhood wheezing.
50 Korppi M. Viral wheezing is virus specific and not just host specific.
51 Korppi M. Are all pneumococcal infections mixed infections with viruses.
52 Korppi M. Does solely clinical diagnostics lead to overdiagnoses and overtreatments. Pneumonia in children.
53 Korppi M. Diagnosis and treatment of community-acquired pneumonia in children.
54 Korppi M. Eosinophil and neutrophil activity in wheezing infants.
55 Korppi M. ICS and bone-mineral density.
56 Korppi M et al. Which is the principal early-life infection-related risk factor for asthma.
57 Korppi M et al. Upper age limit for bronchiolitis: 12 months or 6 months.
58 Koskinen J et al. Effect of age, gender and cardiovascular risk factors on carotid distensibility during 6-year follow-up. The cardiovascular risk in Young Finns study.
59 Kotaluoto S et al. Wound Healing after Open Appendectomies in Adult Patients: A Prospective, Randomised Trial Comparing Two Methods of Wound Closure.
60 Kuikka L, Korppi M. Prevention of asthma in children at risk: avoiding cow's milk for 6 months and tobacco smoke forever - nothing special needed.
61 Kurppa K et al. Factors Associated with Dietary Adherence in Celiac Disease: A Nationwide Study.
62 Kurppa K et al. Ruoansulatuskanavan eosinofiiliset sairaudet.
63 Kurppa K et al. Endomysial antibodies predict celiac disease irrespective of the titers or clinical presentation.
64 Kurppa K et al. Utility of the new ESPGHAN criteria for the diagnosis of celiac disease in at-risk groups.
65 Lahti M et al. Temporary separation from parents in early childhood and serious personality disorders in adult life.
66 Laitinen TT et al. Ideal cardiovascular health in childhood and cardiometabolic outcomes in adulthood: the cardiovascular risk in young Finns study.
67 Lappalainen S et al. Simultaneous presence of human herpesvirus 6 and adenovirus infections in intestinal intussusception of young children.
68 Lehmann A et al. Different in vitro and in vivo profiles of substituted 3-aminopropylphosphinate and 3-aminopropyl(methyl)phosphinate GABA(B) receptor agonists as inhibitors of transient lower oesophageal sphincter relaxation.
69 Lempainen J et al. Effect of the PTPN22 and INS risk genotypes on the progression to clinical type 1 diabetes after the initiation of ß-cell autoimmunity.
70 Lempainen J et al. Interaction of enterovirus infection and cow's milk-based formula nutrition in type 1 diabetes-associated autoimmunity.
71 Lindfors K, Kaukinen K. Contribution of celiac disease autoantibodies to the disease process.
72 Lindfors K, Kaukinen K. Vitamin C as a supplementary therapy for celiac disease.
73 Lindfors K et al. Future treatment strategies for celiac disease.
74 Lindfors K et al. In vitro models for gluten toxicity: relevance for celiac disease pathogenesis and development of novel treatment options.
75 Lindström V et al. Indoleamine 2,3-dioxygenase activity and expression in patients with chronic lymphocytic leukemia.
76 Linka RM et al. Loss-of-function mutations within the IL-2 inducible kinase ITK in patients with EBV-associated lymphoproliferative diseases.
77 Linkosalo L et al. Relation of bronchial and alveolar nitric oxide to exercise-induced bronchoconstriction in atopic children and adolescents.
78 Lohi O, Vettenranta K. Lasten leukemian riskiryhmäjako tarkentuu.
79 Lohi O et al. Recurrent congenital fibrosarcoma with heart metastases.
80 Ludvigsson J et al. GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus.
81 Lumia M et al. Maternal dietary fat and fatty acid intake during lactation and the risk of asthma in the offspring.
82 Luntamo M et al. The effect of monthly sulfadoxine-pyrimethamine, alone or with azithromycin, on PCR-diagnosed malaria at delivery: a randomized controlled trial.
83 Luopajärvi K et al. Expansion of CD4+CD25+FOXP3+ regulatory T cells in infants of mothers with type 1 diabetes.
84 Lähdeaho ML et al. Recent advances in the development of new treatments for celiac disease.
85 Lähteelä K et al. No association of nineteen COX-2 gene variants to preclinical markers of atherosclerosis The Cardiovascular Risk in Young Finns Study.
86 Markula-Patjas K et al. Prevalence of vertebral compression fractures and associated factors in children and adolescents with severe juvenile idiopathic arthritis.
87 Martucciello S et al. RhoB is associated with the anti-angiogenic effects of celiac patient transglutaminase 2-targeted autoantibodies.
88 Mecklin M et al. Salbutamol with metered dose inhalers with spacers - an established emergency treatment for preschool wheeze.
89 Merenmies J et al. Kystinen munuaissairaus ja diabetes - alidiagnosoitu yksigeeninen kehityshäiriö.
90 Meriluoto M et al. Association of human bocavirus 1 infection with respiratory disease in childhood follow-up study, Finland.
91 Mustila T et al. Behavioral counseling to prevent childhood obesity--study protocol of a pragmatic trial in maternity and child health care.
92 Mustila T et al. Lifestyle counseling during pregnancy and offspring weight development until four years of age: follow-up study of a controlled trial.
93 Mustila T et al. Lifestyle counselling targeting infant's mother during the child's first year and offspring weight development until 4 years of age: a follow-up study of a cluster RCT.
94 Myllymäki H, Rämet M. Transcription factor zfh1 downregulates Drosophila Imd pathway.
95 Mäkelä MJ et al. Salmeterol and fluticasone in young children with multiple-trigger wheeze.
96 Mäki M. Coeliac disease: Lack of consensus regarding definitions of coeliac disease.
97 Mäki M, Aine L. Tooth surface loss.
98 Nieminen JK et al. Altered phenotype of peripheral blood dendritic cells in pediatric type 1 diabetes.
99 Nohynek H et al. AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland.
100 Nohynek H et al. Pandemiarokotteen yhteys lasten narkolepsian esiintyvyyden äkilliseen lisääntymiseen Suomessa.
101 Nucci AM et al. Growth differences between North American and European children at risk for type 1 diabetes.
102 Nuolivirta K. Bronchiolitis in early infancy.
103 Nuolivirta K et al. Mannose-binding lectin gene polymorphisms in infants with bronchiolitis and post-bronchiolitis wheezing.
104 Nuolivirta K et al. Toll-like receptor 3 L412F polymorphisms in infants with bronchiolitis and postbronchiolitis wheezing.
105 Nuolivirta K et al. Weight gain in infancy and post-bronchiolitis wheezing.
106 Nwaru BI et al. Maternal intake of fatty acids during pregnancy and allergies in the offspring.
107 Oikarinen M et al. Type 1 diabetes is associated with enterovirus infection in gut mucosa.
108 Oikonen M et al. Associations between serum uric acid and markers of subclinical atherosclerosis in young adults. The cardiovascular risk in Young Finns study.
109 Oilinki T et al. Prevalence and characteristics of diabetes among Somali children and adolescents living in Helsinki, Finland.
110 Oling V et al. Autoantigen-specific memory CD4+ T cells are prevalent early in progression to Type 1 diabetes.
111 Ovaskainen M-L et al. Ateriointi ja ruokatottumukset.
112 Paavola A et al. Gastrointestinal symptoms and quality of life in screen-detected celiac disease.
113 Paavonen EJ, Saarenpää-Heikkilä O. Lapsuuden unihäiriöiden arviointi kliinisessä työssä.
114 Paavonen J, Saarenpää-Heikkilä O. Tarvitaanko unikouluja.
115 Paavonen J, Saarenpää-Heikkilä O. Lapsuusiän unihäiriöiden arviointi kliinisessä työssä.
116 Palonkoski L et al. Lapsuusiän syövän hoitotulokset TAYS-piirin alueella.
117 Parikka M et al. Mycobacterium marinum Causes a Latent Infection that Can Be Reactivated by Gamma Irradiation in Adult Zebrafish.
118 Parikka V et al. Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk.
119 Parmar AS et al. Association study of FUT2 (rs601338) with celiac disease and inflammatory bowel disease in the Finnish population.
120 Partanen M et al. Lasten narkolepsian ilmaantuvuuden lisääntyminen ja kliininen oirekuva vuoden 2009 Pandemrix-rokotekampanjan jälkeen.
121 Partinen M et al. Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland.
122 Patterson H et al. Adult zebrafish model of bacterial meningitis in Streptococcus agalactiae infection.
123 Pauniaho SL et al. The incidences of malignant gonadal and extragonadal germ cell tumors in males and females: a population-based study covering over 40 years in Finland.
124 Peet A et al. Birth weight in newborn infants with different diabetes-associated HLA genotypes in three neighbouring countries: Finland, Estonia and Russian Karelia.
125 Phuka JC et al. Developmental outcomes among 18-month-old Malawians after a year of complementary feeding with lipid-based nutrient supplements or corn-soy flour.
126 Pietilä S. Late effects in pediatric brain tumor survivors.
127 Pietilä S et al. Neurological outcome of childhood brain tumor survivors.
128 Pohjankoski H et al. Simultaneous juvenile idiopathic arthritis and diabetes mellitus type 1 -- a finnish nationwide study.
129 Pohjankoski H et al. Diabetes, coeliac disease, multiple sclerosis and chronic arthritis in first-degree relatives of patients with juvenile idiopathic arthritis.
130 Puustinen L et al. Norovirus genotypes in endemic acute gastroenteritis of infants and children in Finland between 1994 and 2007.
131 Pärnänen A et al. Symptom-detected and screen-detected celiac disease and adult height: a large cohort study.
132 Rantanen K et al. Social competence in children with epilepsy--a review.
133 Ribes-koninckx C et al. Coeliac disease diagnosis: ESPGHAN 1990 criteria or need for a change? Results of a questionnaire.
134 Risku M et al. Human bocavirus types 1, 2 and 3 in acute gastroenteritis of childhood.
135 Rounioja S et al. Defense of zebrafish embryos against Streptococcus pneumoniae infection is dependent on the phagocytic activity of leukocytes.
136 Ruotsalainen M et al. Association between overweight and asthma or allergy: Results from a prospective 27-year post-bronchiolitis follow-up.
137 Rämet M. The fruit fly Drosophila melanogaster unfolds the secrets of innate immunity.
138 Saarenpää-Heikkilä O. Lasten neurologiset unihäiriöt haittaavat päivän toimintoja.
139 Saari A et al. Screening of turner syndrome with novel auxological criteria facilitates early diagnosis.
140 Salo J et al. Cranberry juice for the prevention of recurrences of urinary tract infections in children: a randomized placebo-controlled trial.
141 Salonen A et al. A critical analysis of postoperative complications of antebrachium TEN-nailing in 35 children.
142 Sampson CJ et al. The RhoGEF Zizimin-related acts in the Drosophila cellular immune response via the Rho GTPases Rac2 and Cdc42.
143 Sartoneva R et al. Characterizing and optimizing poly-L-lactide-co-{varepsilon}-caprolactone membranes for urothelial tissue engineering.
144 Schmader KE et al. Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years.
145 Seiskari T et al. Role of enterovirus infections in IgE sensitization.
146 Sidoroff V et al. Overweight does not increase asthma risk but may decrease allergy risk at school age after infantile bronchiolitis.
147 Simon-vecsei Z et al. A single conformational transglutaminase 2 epitope contributed by three domains is critical for celiac antibody binding and effects.
148 Tamminen K et al. A comparison of immunogenicity of norovirus GII-4 virus-like particles and P-particles.
149 Taranukhin AG et al. Taurine protects cerebellar neurons of the external granular layer against ethanol-induced apoptosis in 7-day-old mice.
150 Teittinen KJ et al. SAP30L (Sin3A-associated protein 30-like) is involved in regulation of cardiac development and hematopoiesis in zebrafish embryos.
151 Teittinen KJ et al. The zebrafish as a tool in leukemia research.
152 Teittinen KJ et al. Nucleolar proteins with altered expression in leukemic cell lines.
153 Törnroos M et al. Personality traits of the five-factor model are associated with effort-reward imbalance at work .
154 Ukkola A. The burden of coeliac disease. The perspectives of patients, health care system and society.
155 Ukkola A et al. Use of health care services and pharmaceutical agents in coeliac disease: a prospective nationwide study.
156 Ukkola A et al. Hoitamaton keliakia kuormittaa sekä keliakiaa sairastavaa että terveydenhuoltoa.
157 Ukkola A et al. Changes in body mass index on a gluten-free diet in coeliac disease: A nationwide study.
158 Ukkola A et al. Patients' experiences and perceptions of living with coeliac disease - implications for optimizing care.
159 Vaarala O et al. Removal of Bovine Insulin From Cow's Milk Formula and Early Initiation of Beta-Cell Autoimmunity in the FINDIA Pilot Study.
160 Valanne S et al. Large-scale RNAi screens add both clarity and complexity to Drosophila NF-kB signaling.
161 van Der Meere J et al. Visual orientation in hospitalized boys with early onset conduct disorder and borderline intellectual functioning.
162 van Der Velden Mv et al. Cell culture (Vero cell) derived whole-virus non-adjuvanted H5N1 influenza vaccine induces long-lasting cross-reactive memory immune response: homologous or heterologous booster response following two dose or single dose priming.
163 Vanha-aho LM et al. Functional characterization of the infection-inducible peptide Edin in Drosophila melanogaster.
164 Vesikari T. Rotavirus vaccination: a concise review.
165 Vesikari T et al. Immunogenicity and safety of a two-dose regimen of a combined measles, mumps, rubella and varicella live vaccine (ProQuad(®)) in infants from 9 months of age.
166 Vesikari T et al. Use of real-time polymerase chain reaction (rtPCR) as a diagnostic tool for influenza infection in a vaccine efficacy trial.
167 Vesikari T et al. Immunogenicity, safety and reactogenicity of a mammalian cell-culture-derived influenza vaccine in healthy children and adolescents three to seventeen years of age.
168 Vesikari T et al. Homologous and heterologous antibody responses to a one-year booster dose of an MF59(®) adjuvanted A/H5N1 pre-pandemic influenza vaccine in pediatric subjects.
169 Vesikari T et al. A randomized study to assess the immunogenicity, antibody persistence and safety of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in children aged 2-10 y.
170 Vesikari T et al. Randomized trial to assess the immunogenicity, safety and antibody persistence up to three years after a single dose of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in toddlers.
171 Vesikari T et al. Safety and immunogenicity of an MF59(®)-adjuvanted A/H5N1 pre-pandemic influenza vaccine in adults and the elderly.
172 Vesikari T et al. Assessment of squalene adjuvanted and non-adjuvanted vaccines against pandemic H1N1 influenza in children 6 months to 17 years of age.
173 Vesikari T et al. Efficacy and immunogenicity of live-attenuated human rotavirus vaccine in breast-fed and formula-fed European infants.
174 Viiri K et al. Phosphoinositides as regulators of protein-chromatin interactions.
175 Virta L et al. Association of repeated exposure to antibiotics with the development of pediatric Crohn's disease--a nationwide, register-based finnish case-control study.
176 Virtanen SM et al. Food consumption and advanced ß cell autoimmunity in young children with HLA-conferred susceptibility to type 1 diabetes: a nested case-control design.
177 Viskari H et al. Maternal enterovirus infection as a risk factor for type 1 diabetes in the exposed offspring.
178 Ylänen K et al. Bilateral Absence fo the Superior Vena Cava.
Julkaisutietokanta 11.12.2013 Publications Data Base 11.12.2013